- Home
- BTAI vs SELF Comparison
BTAI vs SELF Comparison
Compare BTAI & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | SELF |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 56.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | BTAI | SELF |
|---|---|---|
| Price | $1.87 | $5.06 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 540.0K | 44.4K |
| Earning Date | 11-12-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 5.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | $752,000.00 | ★ $12,733,279.00 |
| Revenue This Year | N/A | $1.59 |
| Revenue Next Year | $416.40 | $1.62 |
| P/E Ratio | ★ N/A | $30.94 |
| Revenue Growth | N/A | ★ 3.36 |
| 52 Week Low | $1.17 | $4.73 |
| 52 Week High | $9.26 | $5.89 |
Technical Indicators
Market Signals| Indicator | BTAI | SELF |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 44.42 |
| Support Level | $1.82 | $4.95 |
| Resistance Level | $2.30 | $5.10 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 5.83 | 33.33 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.